Local Institution [clinicaltrials_resource:3dd0dc6a2927d42c451d1c75d1eeeee1]
BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia [clinicaltrials:NCT00103701]Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase [clinicaltrials:NCT00324077]
location [clinicaltrials_vocabulary:location]
Local Institution [clinicaltrials_resource:3dd0dc6a2927d42c451d1c75d1eeeee1]
Bio2RDF identifier
3dd0dc6a2927d42c451d1c75d1eeeee1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3dd0dc6a2927d42c451d1c75d1eeeee1
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:3dd0dc6a2927d42c451d1c75d1eeeee1
title
Local Institution
@en
type
label
Local Institution [clinicaltrials_resource:3dd0dc6a2927d42c451d1c75d1eeeee1]
@en